IMed Consultancy explores the pros and cons of the regulatory scenario in key international markets within a changing regulatory environment

IMed Consultancy, a rising regulatory and compliance consultancy provider with over 50 years of experience supporting UK and international medical device and invitro device manufacturers launch and maintain their products on global markets, presents a guide to market entry looking at the EU, the UK and the USA. The whitepaper, available here: https://imedconsultancy.com, looks at these three major markets for medical devices, highlighting some key considerations relating to entering each of these geographies “first” to help manufacturers make informed decisions.

In today’s rapidly evolving landscape of healthcare and technology, navigating the realm of regulatory compliance for medical devices has become an increasingly complex endeavour. With advancements in medical technology, the development and deployment of innovative devices have brought forth immense opportunities for improving patient care and revolutionizing the healthcare industry. At the same time, however, major markets such as Europe and the UK are experiencing unprecedented regulatory shake-ups in the form of the introduction of the new EU MDR and IVDR and the Future UK Regulatory System.

These regulations aim to safeguard patient safety, ensure device effectiveness, and maintain ethical standards throughout the product lifecycle, from design and manufacturing to post-market surveillance. However, achieving regulatory compliance in this intricate landscape is no simple task. It requires a deep understanding of the evolving regulatory landscape, meticulous planning, robust quality management systems, and effective risk assessment strategies.

“Manufacturers and stakeholders must navigate through a web of complex standards, guidelines, and country-specific regulations before they decide which markets will be the most profitable to enter and which ones they should tackle first, laying the groundworks for further expansion in the most time-efficient and cost-effective way possible. We felt the need to try and untangle some of this web for them, to ease their decision process and to hopefully shed some light on the different opportunities these areas have to offer.” comments Leeanne Baker, Managing Director and Quality & Regulatory Consultant.

This article was written by Medilink Midlands Member, IMed Consultancy. For more information on Medilink Midlands Membership, click here

Latest Opportunities

UKHAIC opens Flexible Talent Mobility Account (FTMA) funding call

The FTMA is intended to support secondments and other activities that contribute to the mobility…

V Formation is hiring a Digital Marketing Account Manager

V Formation is seeking an experienced digital marketing account manager or senior exec to join our talented, friendly and…

Businesses can apply for the Birmingham City University micro-placement scheme

Micro-placements offer businesses the opportunity to work with a student or graduate free of charge…

Latest News

What the NHS 10-Year Plan means for innovation - and your business

The government’s new 10-Year Health Plan shows a bold shift in NHS priorities – towards…

Strengthening Transatlantic Ties: Medilink Midlands Trade Mission to Mentor, Ohio

Medilink Midlands is inviting expressions of interest from life science and medtech companies across the…

‘Rebel’ spirit needed to drive healthtech sector growth in the East Midlands, experts say

A recent roundtable hosted by The Boda Group and Shakespeare Martineau echoed what we at…